IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $70,000 | +2.9% | 14,657 | -2.6% | 0.02% | +12.5% |
| Q2 2022 | $68,000 | -5.6% | 15,046 | -0.4% | 0.02% | +14.3% |
| Q1 2022 | $72,000 | -45.9% | 15,106 | -15.5% | 0.01% | -39.1% |
| Q4 2021 | $133,000 | +30.4% | 17,887 | -0.8% | 0.02% | +35.3% |
| Q3 2021 | $102,000 | -14.3% | 18,027 | -0.7% | 0.02% | -15.0% |
| Q2 2021 | $119,000 | -22.2% | 18,159 | -3.7% | 0.02% | -23.1% |
| Q1 2021 | $153,000 | +22.4% | 18,866 | -2.7% | 0.03% | +23.8% |
| Q4 2020 | $125,000 | +76.1% | 19,397 | -1.0% | 0.02% | +61.5% |
| Q3 2020 | $71,000 | -31.1% | 19,589 | -12.3% | 0.01% | -31.6% |
| Q2 2020 | $103,000 | +51.5% | 22,325 | +11.6% | 0.02% | +35.7% |
| Q1 2020 | $68,000 | -20.9% | 20,011 | +19.1% | 0.01% | 0.0% |
| Q4 2019 | $86,000 | +75.5% | 16,808 | -18.3% | 0.01% | +75.0% |
| Q3 2019 | $49,000 | +8.9% | 20,577 | -0.9% | 0.01% | 0.0% |
| Q2 2019 | $45,000 | – | 20,762 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |